Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the src SH2 domain binding

被引:55
作者
Nam, NH
Ye, GF
Sun, GQ
Parang, K [1 ]
机构
[1] Univ Rhode Isl, Dept Biomed Sci, Kingston, RI 02881 USA
[2] Univ Rhode Isl, Dept Cell & Mol Biol, Kingston, RI 02881 USA
关键词
D O I
10.1021/jm040008+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of conformationally constrained peptides were designed and synthesized as the Src SH2 domain ligands based on a tetrapeptide sequence pTyr-Glu-Glu-Ile (pYEEI). In general, the constrained peptides such as compounds 6, 7, and 11 (IC50 = 1.1-1.5 muM) showed higher binding affinities to the Src SH2 domain relative to the corresponding linear peptides 8a, 9a, and 13a, respectively (IC50 > 100 muM), and pYEEI (IC50 = 6.5 muM), as evaluated by a fluorescence polarization assay. Molecular modeling studies revealed that in constrained peptides, the isoleucine side chain penetrates very deeply into the hydrophobic binding pocket (P + 3 site) of the Src SH2 domain. These constrained peptides can serve as novel templates for the design of small and nonpeptidic inhibitors of the Src SH2 domain.
引用
收藏
页码:3131 / 3141
页数:11
相关论文
共 50 条
[11]   Inhibitors of the Src SH2 domain and Src tyrosine kinase as potential anticancer drugs [J].
Tranter, D .
DRUG DISCOVERY TODAY, 2001, 6 (04) :215-216
[12]   Development of peptoid-peptide hybrids as She SH2 domain - binding inhibitors [J].
Kim, Sung-Eun ;
Choi, Won Jun ;
Stephen, Andrew G. ;
Weidlich, Iwona E. ;
Giubellino, Alessio ;
Liu, Fa ;
Worthy, Karen M. ;
Bindu, Lakshman ;
Fivash, Matthew J. ;
Nicklaus, Marc C. ;
Bottaro, Donald ;
Fisher, Robert J. ;
Burke, Terrence R., Jr. .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
[13]   Role of electrostatic interactions in SH2 domain recognition: Salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase [J].
Grucza, RA ;
Bradshaw, JM ;
Mitaxov, V ;
Waksman, G .
BIOCHEMISTRY, 2000, 39 (33) :10072-10081
[14]   Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain [J].
Ye, GF ;
Ayrapetov, M ;
Nam, NH ;
Sun, GQ ;
Parang, K .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (22) :4994-4997
[15]   Synthesis of GRB2 SH2 domain inhibitors: Analogues of sclerotiorin [J].
Gladfelder, Joshua ;
Arpin, Carolynn .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
[16]   USE OF PEPTOID-PEPTIDE HYBRIDS IN THE DEVELOPMENT OF She SH2 DOMAIN -BINDING INHIBITORS [J].
Kim, S. ;
Choi, W. ;
Stephen, A. ;
Weidlich, I. ;
Giubellino, A. ;
Liu, F. ;
Worthy, K. ;
Bindu, L. ;
Fivash, M. ;
Nicklaus, M. ;
Bottaro, D. ;
Fisher, R. ;
Burke, T., Jr. .
BIOPOLYMERS, 2009, 92 (04) :352-352
[17]   Modulation of the SH2 binding specificity and kinase activity of Src by tyrosine phosphorylation within its SH2 domain [J].
Stover, DR ;
Furet, P ;
Lydon, NB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (21) :12481-12487
[18]   Diversity in the SH2 domain family phosphotyrosyl peptide binding site [J].
Campbell, SJ ;
Jackson, RM .
PROTEIN ENGINEERING, 2003, 16 (03) :217-227
[19]   Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing α-methylphenylalanyl based phosphotyrosyl mimetics [J].
Oishi, S ;
Karki, RG ;
Kang, SU ;
Wang, XZ ;
Worthy, KM ;
Bindu, LK ;
Nicklaus, MC ;
Fisher, RJ ;
Burke, TR .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) :764-772
[20]   Potent dipeptide inhibitors of the pp60c-src SH2 domain [J].
Pacofsky, GJ ;
Lackey, K ;
Alligood, KJ ;
Berman, J ;
Charifson, PS ;
Crosby, RM ;
Dorsey, GF ;
Feldman, PL ;
Gilmer, TM ;
Hummel, CW ;
Jordan, SR ;
Mohr, C ;
Shewchuk, LM ;
Sternbach, DD ;
Rodriguez, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (11) :1894-1908